Chargement en cours...
Statistical issues and challenges in immuno-oncology
BACKGROUND: The development of immuno-oncologic agents poses unique challenges, namely that both efficacy and safety profiles differ from previously characterized cytotoxic and pathway-specific agents. In addition, exponential distribution is usually assumed in study designs with time-to-event endpo...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4019889/ https://ncbi.nlm.nih.gov/pubmed/24829754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-1426-1-18 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|